BR9917367A - Método para preparação de citalopram e sua composição farmacêutica - Google Patents

Método para preparação de citalopram e sua composição farmacêutica

Info

Publication number
BR9917367A
BR9917367A BR9917367-0A BR9917367A BR9917367A BR 9917367 A BR9917367 A BR 9917367A BR 9917367 A BR9917367 A BR 9917367A BR 9917367 A BR9917367 A BR 9917367A
Authority
BR
Brazil
Prior art keywords
citalopram
preparation
pharmaceutical composition
compound
caino
Prior art date
Application number
BR9917367-0A
Other languages
English (en)
Inventor
Hans Petersen
Michael Harold Rock
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR9917367A publication Critical patent/BR9917367A/pt

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2282Unsaturated compounds used as ligands
    • B01J31/2295Cyclic compounds, e.g. cyclopentadienyls
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/42Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
    • B01J2231/4205C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/84Metals of the iron group
    • B01J2531/847Nickel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)

Abstract

"MéTODO PARA PREPARAçãO DE CITALOPRAM E SUA COMPOSIçãO FARMACêUTICA". Método para a preparação de citalopram compreendendo reação de um composto de Fórmula IV onde R é Cl ou Br na presença de um, catalisador de níquel e isolamento do composto 5-caino correspondente, ou seja, citalopram.
BR9917367-0A 1999-06-25 1999-11-19 Método para preparação de citalopram e sua composição farmacêutica BR9917367A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900921 1999-06-25
PCT/DK1999/000643 WO2000011926A2 (en) 1999-06-25 1999-11-19 Method for the preparation of citalopram

Publications (1)

Publication Number Publication Date
BR9917367A true BR9917367A (pt) 2002-03-05

Family

ID=8099044

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9917367-0A BR9917367A (pt) 1999-06-25 1999-11-19 Método para preparação de citalopram e sua composição farmacêutica

Country Status (36)

Country Link
US (1) US6750358B2 (pt)
EP (1) EP1105382B1 (pt)
JP (1) JP3389571B2 (pt)
KR (1) KR100491369B1 (pt)
CN (1) CN1129593C (pt)
AR (1) AR020573A1 (pt)
AT (3) ATE213237T1 (pt)
AU (2) AU1374800A (pt)
BG (1) BG106190A (pt)
BR (1) BR9917367A (pt)
CA (1) CA2290125C (pt)
CH (1) CH691304A5 (pt)
CZ (1) CZ292174B6 (pt)
DE (2) DE69900891D1 (pt)
DK (1) DK1105382T3 (pt)
EA (1) EA002661B1 (pt)
ES (1) ES2172356T3 (pt)
FI (1) FI108538B (pt)
GB (1) GB2354240B (pt)
HK (1) HK1047745B (pt)
HU (1) HUP0103417A3 (pt)
IL (1) IL145960A0 (pt)
IS (1) IS5862A (pt)
IT (1) ITMI991579A1 (pt)
MX (1) MXPA01010986A (pt)
NO (1) NO20010318L (pt)
NZ (1) NZ514982A (pt)
PL (1) PL345971A1 (pt)
PT (1) PT1105382E (pt)
SE (1) SE516689C2 (pt)
SI (1) SI1105382T1 (pt)
SK (1) SK18412001A3 (pt)
TR (1) TR200103700T2 (pt)
UA (1) UA62023C2 (pt)
WO (1) WO2000011926A2 (pt)
ZA (1) ZA200108855B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1140886T1 (en) 1998-12-23 2003-08-31 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
ATE237604T1 (de) 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
DE19983836C1 (de) 1999-10-25 2003-10-23 Lundbeck As Valby H Verfahren zur Herstellung von Citalopram, 4-[1-(4- Fluorphenyl)-methanoyl]-benzonitril-Derivate und Verfahren zu deren Herstellung und deren Verwendung
EP1228056B1 (en) 1999-10-25 2004-09-22 H. Lundbeck A/S Method for the preparation of citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
EA004742B1 (ru) 1999-12-28 2004-08-26 Х.Лундбекк А/С Способ получения циталопрама
JP2003519218A (ja) 1999-12-30 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
SI1254129T1 (en) 2000-01-14 2004-02-29 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
NL1017415C1 (nl) 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
CN1429219A (zh) 2000-03-13 2003-07-09 H·隆德贝克有限公司 制备西酞普兰的方法
NZ521204A (en) 2000-03-13 2004-03-26 H Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)- 1,3-dihydroisobenzofurans for preparing citalopram, an anti depressant
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
WO2001068630A1 (en) 2000-03-14 2001-09-20 H. Lundbeck A/S Method for the preparation of citalopram
TR200202168T2 (tr) * 2000-03-16 2002-12-23 H. Lundbeck A/S 5-Siyano-1-(4-Florofenil)-1,3-Dihidroizobenzofuranların preparasyon metodu
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
BR0106976A (pt) * 2000-07-06 2002-07-23 Lundbeck & Co As H Método para a preparação de citalopram
IL144816A (en) * 2000-08-18 2005-09-25 Lundbeck & Co As H Method for the preparation of citalopram
SG167655A1 (en) * 2000-12-22 2011-01-28 Lundbeck & Co As H Method for the preparation of pure citalopram
JP2003519121A (ja) 2000-12-28 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット 純粋なシタロプラムの製造方法
CA2435925A1 (en) 2001-01-30 2002-08-08 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
WO2002072565A1 (en) * 2001-03-09 2002-09-19 Ranbaxy Laboratories Limited Process for the preparation of citalopram
MEP2108A (xx) 2001-07-31 2010-02-10 Lundbeck & Co As H Kristalni sastav koji sadrži escitalopram
WO2003057132A2 (en) 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
AR040970A1 (es) 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
TR200504022T1 (tr) * 2003-03-24 2006-08-21 Hetero Drugs Limited (S)-sitalopram oksalatın yeni sıvı kristal formları.
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
JP2006008603A (ja) * 2004-06-25 2006-01-12 Sumitomo Chemical Co Ltd 光学活性シタロプラムの製造方法、その中間体およびその製造方法
EP2141156A1 (en) 2004-08-23 2010-01-06 Sun Pharma Global FZE Process for Preparation of Citalopram and Enantiomers
WO2006103550A1 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Processes for the preparation of citalopram and its intermediate 5-aminophthalide
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (pt) 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
CA2010159A1 (en) 1989-02-21 1990-08-21 James J. Maul Cyanation of haloaromatics utilizing catalysts generated in situ starting with nic1 or nic1 6h 0
US5296507A (en) 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19706648A1 (de) 1997-02-20 1998-08-27 Bayer Ag Verfahren zur Herstellung von aromatischen Nitrilen
ES2148120T3 (es) 1997-07-08 2002-01-16 Lundbeck & Co As H Metodo para la preparacion de citalopram.
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
ES2149734T3 (es) 1997-11-11 2003-02-16 Lundbeck & Co As H Metodo para la preparacion de citalopram.
CN1129592C (zh) 1998-10-20 2003-12-03 H·隆德贝克有限公司 制备西酞普兰的方法
SI1140886T1 (en) 1998-12-23 2003-08-31 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
DE10015280A1 (de) 1999-03-29 2001-01-04 Nissan Chemical Ind Ltd Verfahren zur Herstellung von Benzonitrilverbindungen
ATE237604T1 (de) 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
EP1228056B1 (en) 1999-10-25 2004-09-22 H. Lundbeck A/S Method for the preparation of citalopram
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
SG167655A1 (en) 2000-12-22 2011-01-28 Lundbeck & Co As H Method for the preparation of pure citalopram
JP2003519121A (ja) 2000-12-28 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット 純粋なシタロプラムの製造方法

Also Published As

Publication number Publication date
EA002661B1 (ru) 2002-08-29
AU2001100433A4 (en) 2001-11-01
ES2172356T3 (es) 2002-09-16
FI20010154A (fi) 2001-02-09
BG106190A (en) 2002-08-30
WO2000011926A3 (en) 2000-06-29
CZ292174B6 (cs) 2003-08-13
NO20010318D0 (no) 2001-01-19
CN1356993A (zh) 2002-07-03
PL345971A1 (en) 2002-01-14
NO20010318L (no) 2001-02-20
SE0100194D0 (sv) 2001-01-24
IL145960A0 (en) 2002-07-25
AT409960B (de) 2002-12-27
SI1105382T1 (en) 2002-06-30
AU2001100433B4 (en) 2002-01-17
HK1047745B (zh) 2004-09-10
MXPA01010986A (es) 2002-06-04
DE19983486T1 (de) 2001-10-18
KR100491369B1 (ko) 2005-05-24
CN1129593C (zh) 2003-12-03
US20020061925A1 (en) 2002-05-23
CZ2001319A3 (en) 2001-05-16
DK1105382T3 (da) 2002-05-27
CH691304A5 (de) 2001-06-29
AU1374800A (en) 2000-03-21
GB0101508D0 (en) 2001-03-07
UA62023C2 (en) 2003-12-15
KR20020011982A (ko) 2002-02-09
TR200103700T2 (tr) 2002-05-21
GB2354240B (en) 2001-05-23
CA2290125C (en) 2004-08-10
AT4366U1 (de) 2001-06-25
SK18412001A3 (sk) 2002-05-09
ZA200108855B (en) 2002-08-28
SE0100194L (sv) 2001-04-25
ATA904099A (de) 2002-05-15
ATE213237T1 (de) 2002-02-15
EP1105382A2 (en) 2001-06-13
SE516689C2 (sv) 2002-02-12
WO2000011926A2 (en) 2000-03-09
JP2002523432A (ja) 2002-07-30
US6750358B2 (en) 2004-06-15
HUP0103417A3 (en) 2003-01-28
EP1105382B1 (en) 2002-02-13
HK1047745A1 (en) 2003-03-07
PT1105382E (pt) 2002-07-31
EA200101071A1 (ru) 2002-02-28
FI108538B (fi) 2002-02-15
GB2354240A (en) 2001-03-21
NZ514982A (en) 2004-01-30
CA2290125A1 (en) 2000-12-25
HUP0103417A2 (hu) 2002-01-28
JP3389571B2 (ja) 2003-03-24
ITMI991579A1 (it) 2001-01-15
IS5862A (is) 2001-02-23
DE69900891D1 (de) 2002-03-21
ITMI991579A0 (it) 1999-07-15
DE19983486C2 (de) 2002-09-05
AR020573A1 (es) 2002-05-15

Similar Documents

Publication Publication Date Title
BR9917367A (pt) Método para preparação de citalopram e sua composição farmacêutica
BR9713363A (pt) Epotilonas c, d, e e f, preparação e composições
BR0108947A (pt) Método para preparação e citalopram; intermediário e sua composição farmacêutica
BR0111667A (pt) Novos compostos
PT1109812E (pt) Pirrolobenzodiazepinas
BR9917346A (pt) Método para preparação de citalopram intermadiário e utilização do mesmo
BR9804815A (pt) "composições antimicrobianas"
HN1998000113A (es) Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
BR0212185A (pt) Compostos e métodos para a preparação de compostos
WO2001032646A3 (en) Sulfonamide derivatives
BR0214666A (pt) Derivados de acetileno tendo atividade antagonìstica de mglur5
BR0214142A (pt) Derivados e intermediários de n-adamantilmetila como composições farmacêuticas e processos para sua preparação
ZA9710796B (en) Oxyiminopregnanecarbolactones.
ES2189489T3 (es) Uso de derivados n-acilvainillinamidicos como agonistas de receptores cb1 perifericos de cannabinoides.
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
SE8904298D0 (sv) New compounds
BR0109022A (pt) Método de preparação de citalopram e sua composição farmacêutica
BR0110996A (pt) Método para preparação de citalopram; composto; intermediário e, sua composição farmacêutica
BR0016781A (pt) Bases de 1-naftol e 2-naftol - mannich substituìdas
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
AR022718A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-olessustituidos con n-(5-fenil-tetrahidrofuranil)metilo y n-(6-fenil-tetrahidropiranil)metilo;procedimientos para prepararlos y su empleo como composiciones farmaceuticas.
BR9913601A (pt) Composto, uso do mesmo, composição farmacêutica, e, processo para a preparação de compostos
BR9907340A (pt) Ciclo-heptenos substituìdos, e processo para a produção de um composto
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.